Skip to content
Recall Observatory FDA recall evidence

Drug product

Xiidra (lifitegrast ophthalmic solution) 5% PROFESSIONAL SAMPLE, packaged in a) 5 single-use containers (0.2 mL each vial) (NDC 54092-606-07) and b) 4 pouches x 5 single-use containers (NDC 54092-606-04), Rx Only, Manufactured for: Shire US Inc., 300 Shire Way, Lexington, MA 02421.

D-0985-2022

May 10, 2022

Class III

Product summary

Firm
Novartis Pharmaceuticals Corporation
Event
Event 90176
Status
Terminated
Classification
Class III
Quantity
279,179 vials
Official record key
drug-enforcement:D-0985-2022

Official wording

Reason: Failed Impurities/Degradation Specifications.

Code information: Lot #: a) and b) 19F39, Exp. Date 06/2022; 19P27, Exp. Date 10/2022; 20CD1, Exp. Date 03/2023

Distribution pattern: Nationwide within the United States

Derived failure modes

  • Potency or specification failure

    reason.potency_specification_failure · v1.0.0

    Failed Impurities/Degradation Specifications